SAN FRANCISCO--(BUSINESS WIRE)--Today, Hinge Health is announcing Enso 3™, a patented, wireless device that is FDA-cleared and clinically-proven to reduce musculoskeletal pain. One in four people with chronic pain experience sudden spikes1 that often disrupt their daily activities and compel them to seek relief.

旧金山--（商业新闻短讯）--今天，铰链健康公司宣布推出Enso 3™，这是一种获得专利的无线设备，经FDA批准并经临床证明可减轻肌肉骨骼疼痛。四分之一的慢性疼痛患者会经历突然的疼痛，这通常会扰乱他们的日常活动，迫使他们寻求缓解。

The new Enso 3 delivers electrical nerve stimulation that achieves non-invasive, non-addictive pain relief within minutes. First shipments of the new Enso are starting this month, with wider availability to all new Hinge Health members starting in 2025..

新的Enso 3提供神经电刺激，在几分钟内实现非侵入性，非成瘾性疼痛缓解。新Enso的首批发货将于本月开始，从2025年开始向所有新的铰链健康成员提供更广泛的供应。。

“A musculoskeletal solution is incomplete without an effective way to help people overcome pain that disrupts their daily activities,” said Daniel Perez, CEO and co-founder of Hinge Health. “Over 100,000 Hinge Health members have benefitted from Enso to date, completing over 3.3 million treatment sessions.

铰链健康公司（Hinge Health）首席执行官兼联合创始人丹尼尔·佩雷斯（DanielPerez）表示：“如果没有有效的方法来帮助人们克服干扰日常活动的疼痛，那么肌肉骨骼的解决方案是不完整的。”。“迄今为止，已有超过10万名铰链健康会员从Enso中受益，完成了330多万次治疗。

We’re thrilled to be shipping this unparalleled hardware-software medical solution to Hinge Health members, empowering them with the industry’s most advanced pain relief device that’s seamlessly integrated with the world’s leading exercise therapy program.”.

我们很高兴能将这一无与伦比的硬件软件医疗解决方案交付给铰链健康会员，为他们提供业界最先进的止痛设备，该设备与世界领先的运动疗法计划无缝集成。”。

The New Enso 3

新Enso 3

Featuring reimagined hardware with new colors, finish, and materials, the small and light Enso 3 attaches to the skin with a reusable gel pad, making it comfortable to wear before exercise therapy or during daily activities affected by pain.

小而轻的Enso 3以全新的颜色、表面处理和材料重新打造的硬件为特色，通过可重复使用的凝胶垫附着在皮肤上，使其在运动治疗前或受疼痛影响的日常活动中穿着舒适。

Enso 3 also introduces new, clinically-proven electrical waveforms customized to different body parts and pain levels. These waveforms are patterns of electrical signals programmed into Enso through software to relieve pain. In addition to the original waveform shown via a peer-reviewed study to reduce pain by over 50%, Enso 3 will ship with two new waveforms targeted at smaller muscles or for people with more sensitivity.

Enso 3还介绍了针对不同身体部位和疼痛程度定制的新的临床验证的电波形。这些波形是通过软件编程到Enso中以缓解疼痛的电信号模式。除了通过同行评审的研究显示的减少50%以上疼痛的原始波形外，Enso 3还将推出两种新波形，针对较小的肌肉或更敏感的人。

Additionally, Enso 3 will deliver new treatments over time with over-the-air software updates, bringing to the device new waveforms released in the future..

此外，随着时间的推移，Enso 3将通过空中软件更新提供新的治疗方法，为设备带来未来发布的新波形。。

To help with member guidance and progress tracking, new Enso 3 features have been integrated into the all-in-one Hinge Health app.

。

Study: Enso Vastly Outperforms Traditional Pain Relief Methods

研究：Enso大大优于传统的止痛方法

In a recent randomized controlled trial involving 325 participants, Enso showed superior pain reduction compared to a traditional Transcutaneous Electrical Nerve Stimulation (TENS) device and exercise therapy alone.

在最近一项涉及325名参与者的随机对照试验中，与传统的经皮神经电刺激（TENS）装置和单独的运动疗法相比，Enso显示出更好的疼痛减轻。

After four weeks, among participants who consistently used their devices, people who used Enso alongside exercise therapy were 2.3 times more likely to achieve clinically meaningful pain reduction than those using traditional TENS devices alongside exercise therapy.

四周后，在一直使用他们的设备的参与者中，与使用传统TENS设备和运动疗法的人相比，在运动疗法的同时使用Enso的人实现临床上有意义的疼痛减轻的可能性高2.3倍。

Enso, coupled with exercise therapy from Hinge Health, is 2.8 times more likely to achieve meaningful pain reduction than exercise therapy alone.

Enso与铰链健康公司的运动疗法相结合，比单独的运动疗法更有可能实现有意义的疼痛减轻。

48.8% of Enso users experienced significant pain improvement, compared to 34.6% of traditional TENS users and 35.9% of those using exercise therapy without Enso.

48.8%的Enso使用者经历了显着的疼痛改善，而传统TENS使用者为34.6%，而没有Enso的运动疗法使用者为35.9%。

'These results demonstrate that Enso is a powerful tool for providing pain relief, enabling individuals to regain their mobility,' said Dr. Amitabh Gulati, MD, Board-Certified Chronic Pain Specialist.2 'Hinge Health offers a robust suite of complementary tools, including the upgraded Enso 3, alongside digital exercise therapy, computer-guided movement feedback, and a comprehensive care team that are proven to help people reduce their reliance on opioids or injections.'.

董事会认证的慢性疼痛专家、医学博士阿米塔布·古拉蒂（AmitabhGulati）博士说：“这些结果表明，Enso是缓解疼痛的有力工具，使个人能够恢复活动能力。”2“铰链健康提供了一套强大的补充工具，包括升级的Enso 3，以及数字运动疗法，计算机引导的运动反馈，以及一个综合护理团队，已被证明可以帮助人们减少对阿片类药物或注射的依赖。”。

About Hinge Health

关于铰链运行状况

Hinge Health is moving people beyond pain by transforming the way it is treated and prevented. We connect people, digitally and in-person, with expert clinical care. Using advanced technology and AI, a team of clinical experts guides people through personalized care directly from their phone. It is proven to reduce pain by 68%, prevent 42% of new opioid prescriptions, and avoid more than half of joint replacement surgeries.

铰链健康通过改变治疗和预防疼痛的方式，使人们摆脱痛苦。我们通过数字和面对面的方式将人们与专家临床护理联系起来。一组临床专家使用先进的技术和人工智能，直接从手机上引导人们进行个性化护理。事实证明，它可以减轻68%的疼痛，防止42%的新阿片类药物处方，并避免超过一半的关节置换手术。

Available to 18M people, Hinge Health is trusted by leading health plans and employers, including Land O’Lakes, L.L. Bean, Salesforce, Self-Insured Schools of California, Southern Company, US Foods, and Verizon..

铰链健康可供1800万人使用，受到领先健康计划和雇主的信任，包括兰德·奥莱克斯、L.L.比恩、Salesforce、加州自保学校、南方公司、美国食品和Verizon。。

Learn more about how we are inspiring people to improve their health through the power of movement http://www.hingehealth.com.

了解更多有关我们如何通过运动的力量激励人们改善健康的信息http://www.hingehealth.com.

_________________

_________________

1 Based on a 2024 internal analysis of Hinge Health data on chronic program participants.

1基于2024年对慢性项目参与者铰链健康数据的内部分析。

2 Dr. Gulati is a member of Hinge Health’s Clinical Advisory Board and an author of this study.

2 Gulati博士是铰链健康临床咨询委员会的成员，也是本研究的作者。